Curaxis Pharmaceutical Corp. Chief Executive Officer Comments on Recent National Institutes of Health (NIH) Research

SWAMPSCOTT, Mass., May 10, 2011 (GLOBE NEWSWIRE) -- Patrick S. Smith, President and Chief Executive Officer of Curaxis Pharmaceutical Corporation (OTCBB:CURX) (“Curaxis” or the “Company”), commented today on a paper recently published by the National Institute of Health (NIH) entitled “Gonadotropin-releasing hormone receptor system: modulatory role in aging and neurodegeneration.”

MORE ON THIS TOPIC